Enovis (ENOV) Non-Current Deferred Tax Liability (2010 - 2011)
Enovis' (ENOV) quarterly Non-Current Deferred Tax Liability came in at $13.1 million in Q4 2011, down 2.84% year-on-year from $13.5 million in Q4 2010, and down 17.47% on a QoQ basis from $15.9 million in Q3 2011.
Enovis (ENOV) Non-Current Deferred Tax Liability (2010 - 2011) Analysis & Trends
Enovis (ENOV) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $13.1 million in Q4 2011.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 2.84% year-over-year to $13.1 million in Q4 2011; TTM through Dec 2011 was $13.1 million, a 2.84% decrease from a year earlier, with the FY2011 full-year figure at $13.1 million, down 2.84% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2011 stood at $13.1 million, down from $15.9 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for ENOV reached as high as $16.7 million in Q3 2011 and fell as low as $13.1 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 13.15 Mn |
| Dec 31, 2011 | 13.15 Mn |
| Sep 30, 2011 | 15.93 Mn |
| Sep 30, 2011 | 15.93 Mn |
| Jul 1, 2011 | 16.71 Mn |
| Jul 1, 2011 | 16.71 Mn |
| Dec 31, 2010 | 13.53 Mn |
| Dec 31, 2010 | 13.53 Mn |